Fatal Flaws: Unveiling the Human Toll of Compromised Drug Manufacturing

The recent Bloomberg post by Kendall Taggart and Priyanka Pulla highlights the tragic consequences of compromised drug manufacturing, specifically focusing on an Indian pharmaceutical supplier, Naprod Life Sciences. The narrative revolves around an investigative report shedding light on the distressing aftermath of contaminated medications distributed by Naprod. In Colombia, four children lost their lives, and over a hundred ...

Urgent Health Advisory: Substandard Medicines Alert – WHO N°8/2023

Medical Product Alert N°8/2023 Substandard (contaminated) syrup and suspension medicines have been identified in multiple WHO regions, including the Americas, Eastern Mediterranean, Southeast Asia, and the Western Pacific. Five products from PHARMIX LABORATORIES (PVT.) LTD, including ALERGO Syrup and ULCOFIN Suspension, have been found with dangerous levels of ethylene glycol, posing severe health risks like ...

E-Drug Relaunch: Welcome to E-Drug Plus

The E-Drug Community is thrilled to reintroduce E-Drug as E-Drug Plus, aiming to offer the same engagement opportunities as before! By registering at https://talk.edrugplus.org/login and resetting your password using your previous email, you’ll regain access to the familiar email digests and enjoy interactive features on the new platform. Dive back into the community and stay informed!  ...

Inside the 2023 UN Pharma Quality Summit in Copenhagen

This week, we had the privilege to participate in the 2023 Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen. It was an opportunity to learn from colleagues about the latest developments around the UN organisations’ approach to pharmaceutical quality assurance and procurement. The session on Regulatory Updates was especially interesting.  It ...

QUAMED Engages in CIP GSG’s Strategic Summit for Regulatory Systems Strengthening

Last week, QUAMED participated in the second formal meeting of the CIP Global Steering Group (GSG) held on 9-10th November 2023 in the Hague, Netherlands. CIP (Coalition of Interested Parties) is a network for regulatory systems strengthening established by the World Health Organization (WHO) to promote a unified, strategic and coordinated approach to national and ...

Rafaella’s Literature Update

The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, After a few ‘silent’ weeks, I would like to share with you three papers, all somehow related to antibiotic quality and/or rational use. Depending on your personal interests and background in the related disciplines, you ...

Board Meeting updates!

Exciting news from our recent Board of Directors meeting on September 29-30, 2023! We’re thrilled to welcome Concern Worldwide as an associative member and AMEX Healthcare GmBH as an adherent member. Our Strategic Business Plan for 2024-2026 is in progress, and we’ll be seeking your input soon. Stay tuned for updates on the QUAMED Technical ...

Exciting News About QUAMED: Dr. Patrick H. Lukulay Appointed as President

The QUAMED board of directors had its annual in-person meeting in Brussels last week. We are pleased to announce that the board of directors has appointed Dr. Patrick Lukulay, Ph.D. as President of our association. In that capacity, he will chair the QUAMED board of directors. He is replacing Daniel Vandenbergh who has been the ...

Raffaella’s Literature Update

The following message is courtesy of Dr. Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Dear Friends, In the attached paper, Tharmalinga and colleagues share some interesting findings from the national regulatory authority in Sri Lanka. Doing secondary research on data routinely collected for regulatory oversight, the authors investigated the patterns of the medicines ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.